ClinConnect ClinConnect Logo
Search / Trial NCT06324682

ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

Launched by UNIVERSITY HOSPITAL OF FERRARA · Mar 19, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Pace Maker (Pm) Implantable Cardioverter Defibrillator (Icd) Atrioventricular Block Bradyarrhythmia Ventricular Dysfunction Cardiac Resynchronization Therapy Conduction System Pacing His Pacing Left Bundle Branch Area Pacing (Lbbap) Crt Csp Primary Prevention Secondary Prevention Atrioventricular Block Complete Heart Failure Ventricular Arrythmia Ventricular Fibrillation Ventricular Tachycardia

ClinConnect Summary

The ConTempoRary Cardiac Stimulation study is looking at how well different methods of implanting pacemakers and defibrillators work for patients with heart rhythm problems. The researchers want to understand the safety and effectiveness of these procedures and see how advanced imaging techniques can help during the implantation process. This is important because it can lead to better care for patients with conditions like heart failure, arrhythmias, and other issues that affect the heart's ability to pump blood effectively.

To join this study, participants need to be at least 18 years old and have a medical reason to receive a pacemaker or defibrillator. If you decide to participate, you'll receive a permanent device to help manage your heart condition, and the doctors will closely monitor the procedure to ensure everything goes smoothly. This research is still looking for volunteers, and it aims to improve treatment options for many people with serious heart issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Indication for cardiac stimulation
  • Having performed the implantation of a device for cardiac stimulation
  • Exclusion Criteria:
  • Age \< 18 years;
  • Pregnancy status;

About University Hospital Of Ferrara

The University Hospital of Ferrara, a leading academic medical institution in Italy, is dedicated to advancing healthcare through innovative research and clinical excellence. Affiliated with the University of Ferrara, the hospital is known for its commitment to integrating cutting-edge scientific inquiry with patient care. With a multidisciplinary approach, the institution conducts a wide range of clinical trials aimed at enhancing treatment methodologies and improving patient outcomes in various medical fields. The University Hospital of Ferrara prioritizes ethical standards and patient safety, fostering a collaborative environment that engages researchers, healthcare professionals, and patients in the pursuit of medical advancement.

Locations

Empoli, , Italy

Ravenna, , Italy

Firenze, , Italy

Modena, , Italy

Arezzo, , Italy

Pisa, , Italy

Cesena, , Italy

Siena, , Italy

Firenze, , Italy

Palermo, , Italy

Fidenza, , Italy

Lucca, , Italy

Forlì, , Italy

Ferrara, Fe, Italy

Bologna, , Italy

Bologna, , Italy

Carpi, , Italy

Cento, , Italy

Firenze, , Italy

Foggia, , Italy

Grosseto, , Italy

Lido Di Camaiore, , Italy

Livorno, , Italy

Massa, , Italy

Modena, , Italy

Palermo, , Italy

Parma, , Italy

Piacenza, , Italy

Pisa, , Italy

Reggio Emilia, , Italy

Rimini, , Italy

Patients applied

0 patients applied

Trial Officials

Matteo Bertini, MD, PhD

Principal Investigator

Azienda Ospedaliero Universitaria di Ferrara

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported